Oramed to Present at BIO CEO and Investor and Disruptive Growth and Healthcare Conferences

JERUSALEM, Feb. 7, 2017  /PRNewswire/ — Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that the Company will participate in the upcoming BIO CEO & Investor Conference, taking place February 13-14, 2017 in New York City, and the 2017 Disruptive Growth and […]